Literature DB >> 16766838

Nasal extranodal NK/T-cell lymphoma presenting as a perforating palatal ulcer: a diagnostic challenge.

Vidula Patel1, Sunanda Mahajan, Vidya Kharkar, Uday Khopkar.   

Abstract

A 40-year-old man presented with chronic nasal stuffiness and bloodstained discharge of 3 years' duration, along with a non-healing palatal ulcer since 2 months. Examination revealed a perforation in the midline on the hard palate and a superficial ulcer on the soft palate. Histopathology and immunohistochemistry suggested a diagnosis of extranodal nasal/nasal-type T-cell lymphoma. The patient was started on multiagent chemotherapy in the form of cyclophosphamide, doxorubicin, vincristine and prednisolone but succumbed after two cycles. Only one case of nasal T cell lymphoma presenting as nasal septal perforation, oronasal fistula and a concomitant palatal ulcer has been described. We report this case of a perforating palatal ulcer as a rare presentation of nasal lymphoma.

Entities:  

Mesh:

Year:  2006        PMID: 16766838     DOI: 10.4103/0378-6323.25784

Source DB:  PubMed          Journal:  Indian J Dermatol Venereol Leprol        ISSN: 0378-6323            Impact factor:   2.545


  4 in total

1.  Extranodal natural killer/T cell lymphoma, nasal type presenting as a palatal perforation and naso-oral fistula.

Authors:  Vijaya Raj Bhatt; Bibek Koirala; Terenig Terjanian
Journal:  BMJ Case Rep       Date:  2011-03-01

2.  Sinonasal T cell lymphoma: a case report.

Authors:  Deviprasad Shetty; Rajeshwari Aroor; K S Gangadhara Somayaji; Mohammed Tahir; N A Mohammad
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2011-04-10

3.  Extranodal NK/T Cell Lymphoma with Destruction of the Uvulae: A Case Report.

Authors:  Farahzad Jabbari Azad; Zahra Delavarian; Masoud Hatami; Hosein Rahimi; Mohammad Reza Abdolvahed
Journal:  Iran J Otorhinolaryngol       Date:  2017-03

4.  Lethal midline granuloma.

Authors:  Varuna Mallya; Avninder Singh; Manish Pahwa
Journal:  Indian Dermatol Online J       Date:  2013-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.